OSAIC HOLDINGS, INC. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$2,223,804
+34.3%
143,732
+36.4%
0.00%0.0%
Q2 2023$1,655,682
-1.1%
105,401
+3.8%
0.00%0.0%
Q1 2023$1,674,228
+9.8%
101,559
+4.0%
0.00%0.0%
Q4 2022$1,524,178
+24.5%
97,608
+3.5%
0.00%0.0%
Q3 2022$1,224,000
-16.3%
94,352
-9.5%
0.00%0.0%
Q2 2022$1,463,000
-24.3%
104,274
+5.7%
0.00%
-25.0%
Q1 2022$1,933,000
+38.7%
98,617
-3.5%
0.00%
+33.3%
Q4 2021$1,394,000
-28.7%
102,170
-14.2%
0.00%
-25.0%
Q3 2021$1,956,000
-7.9%
119,102
-5.6%
0.00%
-20.0%
Q2 2021$2,123,000
+9.0%
126,112
+18.3%
0.01%0.0%
Q1 2021$1,948,000
+14.5%
106,594
+13.8%
0.01%0.0%
Q4 2020$1,702,000
+18.9%
93,688
+16.6%
0.01%
+25.0%
Q3 2020$1,432,000
+16.2%
80,374
+16.9%
0.00%0.0%
Q2 2020$1,232,000
+20.5%
68,740
+2.9%
0.00%0.0%
Q1 2020$1,022,00066,8170.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders